goldennet

Overview

TLC is committed to creating solutions that address longstanding drug development challenges by enabling therapies with entirely unique properties. Our proprietary LipAD® platforms allow nanoscale design of medicines to improve drug solubility, protect molecules from degradation, and target delivery to specific tissues and cellular compartments. This creates longer-lasting, more effective drugs and enables new therapeutic mechanisms otherwise impractical.

These versatile lipid-based technologies streamline development of enhanced formulations for well-known drugs by optimizing their clinical profile. LipAD® turns pharmaceutical challenges into opportunities.

• BioSeizer®
• NanoX®
• Gene Therapy